Top Stories

Social media app Snapchat has introduced a new location service, Snap Map, that will allow users of the app to see the location of all their friends on a map. The new feature will essentially allow a user to see where his friends are hanging out and...

Bank of America Merrill Lynch has downgraded its outlook on U.S. gross domestic product in 2018 to 2.1 percent from an earlier forecast of 2.5 percent. "Hopes for a big fiscal stimulus have faded, prompting us to remove most of the fiscal impulse from...


President Donald Trump has indicated he is troubled by the friendship between former FBI Director James Comey and Special Counsel Robert Mueller. Trump told "Fox & Friends" in an interview that aired on Friday that Mueller is an "honorable man" and...


After closing mixed for two consecutive sessions, stocks turned in another relatively lackluster performance during trading on Friday. The major averages eventually closed on opposite sides of the unchanged line for the third straight day.


Johnny Depp's comment about assassinating the U.S. president has sparked controversy. Depp was introducing his 2004 movie "The Libertine" at the Glastonbury festival in the English county of Somerset, when he asked: "Can you bring Trump here?" As...

Pharma-061317.jpg Today's Daily Dose brings you news about Celgene's MAGNIFY study results; FDA approval of Ipsen's expanded use of Dysport; Genmab getting milestone payment after FDA approves expanded use of Darzalex and encouraging trial results of Xencor's XmAb5871 in patients with active IgG4-Related Disease.
Asian-Markets1_18Jun17.jpg Asian stock markets are mostly in positive territory on Monday despite the mixed cues from Wall Street on Friday. News that French President Emmanuel Macron's party won a clear parliamentary majority at the weekend boosted investor sentiment. The result gives the 39-year-old president a strong mandate in parliament to pursue his pro-EU, business-friendly reform plans.
stockhigh1-061917.jpg European stocks are likely to open higher on Monday after French President Emmanuel Macron's centrist party won a decisive majority in parliamentary elections, sweeping aside established parties and giving the rookie president a mandate to push through...
Paycom-press-release-061917.jpg Shares of Paycom Software Inc. (PAYC) are up over 50% year-to-date compared to a modest 18% rise by Dow Jones U.S. Software Index for the same period.
Trump-Sign-062317.jpg As part of a continuing effort to address the Veterans Affairs scandal that broke in 2014, President Donald Trump on Friday signed legislation known as the Veterans Affairs Accountability and Whistleblower Protection Act into law.
LorettaLynch-062317.jpg Leaders of the Senate Judiciary Committee revealed Friday they are seeking information about alleged political interference by then-Attorney General Loretta Lynch during the FBI's investigation of former Secretary of State Hillary Clinton's use of a private email server.
Eurozonepmi-062317.jpgEurozone private sector growth moderated in June from a six-year high due to a slowdown in services activity, yet the economy enjoyed the best quarter for six years, the flash data from the Purchasing Managers' survey by IHS Markit showed Friday. The composite output index fell to 55.7 in June from a joint six-year high of 56.8 in May.
Senate Republicans plan to vote on their bill to repeal and replace Obamacare as soon as next week, although the results of a CBS News poll show the vast majority of Americans are unclear about what the legislation will do. Seventy-six percent of Americans said they have not heard enough about the GOP healthcare plan.
The Swiss stock market ended Friday's session with a small loss, but managed to hold above the 9,000 point level. Investors remained focused on the low price of crude oil at the end of the trading week, following its recent collapse. Despite the slight dip during Friday's session, the market managed...
Sprint's prepaid brand Virgin Mobile said it will offer customers a year of its new unlimited data plan for a base price of $1, with the offer available exclusively on the purchase of an iPhone and with AutoPay. The company added that it will be the first ever iPhone-only mobile carrier in the U.S.
Today's Daily Dose brings you news about Amgen's regulatory catalyst for next February; Axsome's new addition to its Board; Clovis' ARIEL3 results; Exelisis' CABOSUN study; Lipocine's study results of oral testosterone candidate LPCN 1021; FDA approval of Neos' ADHD medication and Seattle Genetics' CASCADE disappointment. More
Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, announced Thursday that the U.S. Food and Drug Administration has granted Orphan Drug Designation to omaveloxolone for the treatment of Friedreich's ataxia. Friedreich's... More
Peru's Minister of Economy and Finance Alfredo Thorne stepped down yesterday after losing a confidence vote in Congress. Lawmakers voted on the issue after a recording showed Thorne pressuring the country's comptroller, Edgar Alarcon, to approve the construction of a new airport in Cuzco.
snapchat-062317.jpg Social media app Snapchat has introduced a new location service, Snap Map, that will allow users of the app to see the location of all their friends on a map. The new feature will essentially allow a user to see where his friends are hanging out and what they are up to and also share his own location with friends in real time.
Follow RTT
Economic Calendar
06/23/17 13:0Baker Hughes - Rig CountJUN 23 United States
06/23/17 10:0New Home Sales - UnitsMAY United States
06/23/17 10:0New Home Sales - Median PricesMAY United States
06/23/17 9:45PMI ManufacturingJUN P United States
06/23/17 9:45PMI CompositeJUN P United States
06/23/17 9:45PMI ServicesJUN P United States
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
09/14/17AMGNABP 215 (Biosimilar BLA)FDA decision on ABP 215, a biosimilar candidate to Roche's Avastin
09/03/17MYLMYL-1401O (BLA)FDA decision on MYL-1401O as a proposed biosimilar to Roche's Herceptin
08/30/17TEVASD-809 (NDA)FDA decision on SD-809 for the treatment of tardive dyskinesia
08/30/17CELGEnasidenib (NDA)FDA decision on Enasidenib for the treatment of relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase 2 (IDH2) mutation
08/27/17PFEAvelumab (BLA)FDA decision on Avelumab for treatment of metastatic urothelial carcinoma
Complete FDA Calendar